🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-center, prospective, single-arm, open-label phase II study...
Status
Completed
Location
Asan Medical Center
Start Date
2012-09
Trial ID
NCT01719549
Treatments Being Tested
This study will evaluate the efficacy of TKI258 in patients with advanced u...
Status
Completed
Location
University of California San Diego - Moores Cancer Center UCSD
Start Date
2010-03
Trial ID
NCT00790426
Treatments Being Tested
The goal of this clinical research study is to learn if dovitinib can safel...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-11
Trial ID
NCT01266070
Treatments Being Tested
The primary objective is to determine the maximum tolerated dose (MTD), dos...
Status
Terminated
Location
The University of Texas, M.D. Anderson Cancer Center
Start Date
2004-09
Trial ID
NCT00279773
Treatments Being Tested
In this study with a modified 3+3 dose finding design, a safe and tolerable...
Status
Unknown
Location
Department of Neurology and Center of Integrated Oncology, University Hospital Bonn
Start Date
2013-10
Trial ID
NCT01972750
Treatments Being Tested
This is a prospective, multi-center, open-label, single-arm, non-randomized...
Status
Completed
Location
University of South Alabama / Mitchell Cancer Institute Univ South Alabama
Start Date
2011-11
Trial ID
NCT01379534
Treatments Being Tested
This phase I trial is studying the side effects and best dose of dovitinib ...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2012-03-29
Trial ID
NCT01497392
Phase I dose finding study in solid tumors....
Status
Terminated
Location
Novartis Investigative Site
Start Date
2003-12
Trial ID
NCT01270906
Treatments Being Tested
The main purpose of this study is to find out how useful dovitinib is when ...
Status
Unknown
Location
Auckland Hospital
Start Date
2012-03
Trial ID
NCT01791387
Treatments Being Tested
* Design: non-randomized, open label, phase II clinical trial. * Study popu...
Status
Completed
Location
Complejo Hospitalario Universitario de Santiago
Start Date
2012-01
Trial ID
NCT01514526
Treatments Being Tested